ARTIVION, INC. Repayments of Long-Term Debt
ARTIVION, INC. (AORT) reported Repayments of Long-Term Debt of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2026-08-07
- ARTIVION, INC. repayments of long-term debt for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- ARTIVION, INC. repayments of long-term debt for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- ARTIVION, INC. repayments of long-term debt for the quarter ending 2025-12-31 was $3.00K, a 95.45% decline year-over-year.
- ARTIVION, INC. repayments of long-term debt for the quarter ending 2025-09-30 was $73.00K, a 5.19% decline year-over-year.
- ARTIVION, INC. repayments of long-term debt for fiscal 2025 was $210.00K, a 99.90% decline from fiscal 2024.
- ARTIVION, INC. repayments of long-term debt for fiscal 2024 was $211.83M, a 7541.81% increase from fiscal 2023.
- ARTIVION, INC. repayments of long-term debt for fiscal 2023 was $2.77M, a 0.69% increase from fiscal 2022.
- ARTIVION, INC. repayments of long-term debt for fiscal 2022 was $2.75M, a 1.18% decline from fiscal 2021.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $0.00 10-Q · filed 2026-08-07 | $3.00K derived: sum of 3 quarters · filed 2026-08-07 | $76.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-08 | $3.00K derived: sum of 2 quarters · filed 2026-05-08 | $76.00K derived: sum of 3 quarters · filed 2026-05-08 | $144.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $76.00K derived: sum of 2 quarters · filed 2026-02-18 | $144.00K derived: sum of 3 quarters · filed 2026-08-07 | $210.00K 10-K · filed 2026-02-18 |
| 2025-09-30 | $73.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $141.00K derived: sum of 2 quarters · filed 2026-08-07 | $207.00K 10-Q · filed 2025-11-07 | $273.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $68.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $134.00K 10-Q · filed 2026-08-07 | $200.00K derived: sum of 3 quarters · filed 2026-08-07 | $277.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $66.00K 10-Q · filed 2026-05-08 | $132.00K derived: sum of 2 quarters · filed 2026-05-08 | $209.00K derived: sum of 3 quarters · filed 2026-05-08 | $270.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $66.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $143.00K derived: sum of 2 quarters · filed 2026-02-18 | $204.00K derived: sum of 3 quarters · filed 2026-02-18 | $211.83M 10-K · filed 2026-02-18 |
| 2024-09-30 | $77.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $138.00K derived: sum of 2 quarters · filed 2025-11-07 | $211.76M 10-Q · filed 2025-11-07 | $212.47M derived: sum of 4 quarters · filed 2026-02-18 |
| 2024-06-30 | $61.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $211.69M 10-Q · filed 2025-08-08 | $212.40M derived: sum of 3 quarters · filed 2026-02-18 | $213.08M derived: sum of 4 quarters · filed 2026-02-18 |
| 2024-03-31 | $211.63M 10-Q · filed 2025-05-06 | $212.34M derived: sum of 2 quarters · filed 2026-02-18 | $213.02M derived: sum of 3 quarters · filed 2026-02-18 | $213.71M derived: sum of 4 quarters · filed 2026-02-18 |
| 2023-12-31 | $709.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $1.39M derived: sum of 2 quarters · filed 2026-02-18 | $2.08M derived: sum of 3 quarters · filed 2026-02-18 | $2.77M 10-K · filed 2026-02-18 |
| 2023-09-30 | $682.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $1.37M derived: sum of 2 quarters · filed 2024-11-08 | $2.06M 10-Q · filed 2024-11-08 | $2.78M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $691.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $1.38M 10-Q · filed 2024-08-09 | $2.10M derived: sum of 3 quarters · filed 2025-02-28 | $2.76M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $690.00K 10-Q · filed 2024-05-07 | $1.41M derived: sum of 2 quarters · filed 2025-02-28 | $2.07M derived: sum of 3 quarters · filed 2025-02-28 | |
| 2022-12-31 | $720.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $1.38M derived: sum of 2 quarters · filed 2025-02-28 | $2.75M 10-K · filed 2025-02-28 | |
| 2022-09-30 | $663.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $2.03M 10-Q · filed 2023-11-03 | ||
| 2022-06-30 | $1.37M 10-Q · filed 2023-08-04 | |||
| 2021-12-31 | $2.79M 10-K · filed 2024-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |